Survodutide

Survodutide is an investigational dual GLP-1 and glucagon receptor agonist studied for obesity, liver fat, metabolic regulation, and body-composition research. Its GLP-1 activity is associated with appetite and glucose-control pathways, while glucagon receptor activity is studied for effects on energy expenditure, lipid metabolism, and hepatic fat handling. Researchers are particularly interested in survodutide because it may provide insight into how metabolic and liver-directed pathways overlap. It is frequently examined in the context of weight regulation, visceral fat, MASH-related research, glucose handling, and next-generation multi-agonist therapeutic design.